Equity · Healthcare
CORT
Corcept Therapeutics Incorporated · NasdaqCM
The line runs $60 on 26 May through $91 on 27 July, on a scale from $40 to $100. Days the market did not trade hold the previous close, flat.
The chart above plots the price of CORT over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 43 sessions over that window: $60 on 26 May 2026 through $91 on 27 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 20, 2026
CORT insider trades
CORT has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 17 March 2026.
Showing the 12 most recent of 35 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 56 compensation filings in this window. The figures above count all of them.
CORT reported financials
CORT reported revenue of $761.4M for the fiscal year ended 31 Dec 2025. Net income over the same period was $99.7M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
CORT earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
CORT institutional holders
10 of the 45 institutional funds we track reported a CORT position for the quarter ended 30 Jun 2026 — a combined $848.5M; the latest of those filings landed 14 Aug 2026.
Source: SEC EDGAR 13F filings
CORT fails-to-deliver
On 31 Jul 2026, 242,856 shares of CORT failed to deliver (about $28.7M).
Source: SEC fails-to-deliver (CNS) data